| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/08/2009 | CA2396344C Polymer blends as biodegradable matrices for preparing biocomposites |
| 09/08/2009 | CA2384422C Method for producing a tablet made of isomaltulose, isomalt or isolmalt variants |
| 09/08/2009 | CA2360220C Oxadiazole compounds and compositions for delivering active agents |
| 09/08/2009 | CA2358493C Edible coating composition |
| 09/08/2009 | CA2312840C The use of polyols in combating yeast infection and polyol preparations for said use |
| 09/08/2009 | CA2263070C Oral composition |
| 09/08/2009 | CA2261799C Composition comprising insulin and insulin-like growth factor-i (igf-i) |
| 09/08/2009 | CA2224074C System and method for producing drug-loaded microparticles |
| 09/08/2009 | CA2210872C Dried composition |
| 09/07/2009 | CA2624883A1 Directed therapy |
| 09/03/2009 | WO2009108935A2 Method and apparatus for impregnating porous biomaterials with bioactive agents |
| 09/03/2009 | WO2009108932A2 Selectin ligands useful in the diagnosis and treatment of cancer |
| 09/03/2009 | WO2009108890A1 Methods and compositions for delivering interleukin-1 receptor antagonist |
| 09/03/2009 | WO2009108867A1 Methods of treating cardiovascular disorders associated with atherosclerosis |
| 09/03/2009 | WO2009108865A2 Tablets and preparation thereof |
| 09/03/2009 | WO2009108828A2 Solubility-enhanced forms of aprepitant and pharmaceutical compositions thereof |
| 09/03/2009 | WO2009108824A1 Valsartan solid oral dosage forms and methods of making such formulations |
| 09/03/2009 | WO2009108822A1 Engineered tunable nanoparticles for delivery of therapeutics, diagnostics, and experimental compounds and related compositions for therapeutic use |
| 09/03/2009 | WO2009108775A2 Process to minimize polymorphism |
| 09/03/2009 | WO2009108760A2 Dendritic macroporous hydrogels prepared by crystal templating |
| 09/03/2009 | WO2009108690A1 Composition comprising sirna-polycation complex for iontophoresis |
| 09/03/2009 | WO2009108689A1 Sugar glassified virus like particles (vlps) |
| 09/03/2009 | WO2009108686A1 Composition comprising protein-liposome complex for iontophoresis |
| 09/03/2009 | WO2009108659A1 Delivery apparatus and associated method |
| 09/03/2009 | WO2009108577A2 Use of black soybean for treating ophthalmic diseases |
| 09/03/2009 | WO2009108554A2 System for delivery of protein in insoluble fibrillar or aggregate form |
| 09/03/2009 | WO2009108407A1 Biodegradable therapeutic nanoparticles containing an antimicrobial agent |
| 09/03/2009 | WO2009108308A1 Sweetened capsules for administration |
| 09/03/2009 | WO2009108077A2 Pharmaceutical composition for poorly soluble drugs |
| 09/03/2009 | WO2009108005A2 Composition and method for screening active material used for the prevention and treatment of diabetes or obesity using senp2 and composition for the prevention and treatment of diabetes or obesity |
| 09/03/2009 | WO2009107983A2 Stabilized single-liquid pharmaceutical composition containing docetaxel |
| 09/03/2009 | WO2009107864A2 An orally disintegrating tablet |
| 09/03/2009 | WO2009107759A1 Prophylactic or therapeutic agent for ocular disease accompanied by optic nerve disorder |
| 09/03/2009 | WO2009107753A1 Liposome for delivery to posterior segment of eye and pharmaceutical composition for disease in posterior segment of eye |
| 09/03/2009 | WO2009107683A1 Method for preparation of aqueous emulsion using interfacially active organic compound as emulsifying agent |
| 09/03/2009 | WO2009107479A1 Patch |
| 09/03/2009 | WO2009107478A1 Adhesive skin patch and packaged product |
| 09/03/2009 | WO2009107477A1 Medicated patch |
| 09/03/2009 | WO2009107476A1 Medicated patch |
| 09/03/2009 | WO2009106997A2 Amorphous arformoterol l-(+)-tartrate |
| 09/03/2009 | WO2009106960A2 Stable compositions of lamivudine, tenofovir and efavirenz |
| 09/03/2009 | WO2009106954A1 Stable dosage forms of lamivudine and tenofovir |
| 09/03/2009 | WO2009106831A2 Pharmaceutical composition |
| 09/03/2009 | WO2009106824A2 Pharmaceutical formulations |
| 09/03/2009 | WO2009106714A2 Self-emulsifiable liquid florfenicol composition intended to be incorporated into the drinking water of livestock animals |
| 09/03/2009 | WO2009106555A2 Sterilized sucralfate gel |
| 09/03/2009 | WO2009106333A1 Nanosuspension with antifungal medication to be administered via inhalation with improved impurity profile and safety |
| 09/03/2009 | WO2009106087A1 Drug for dermal use for treating dermatophysis |
| 09/03/2009 | WO2009105937A1 A vinorelbine soft capsule and its preparation method and application. |
| 09/03/2009 | WO2009105912A1 A fat emulsion containing ganoderma spore oil, its quality control methods and its use |
| 09/03/2009 | WO2009089011A3 Resveratrol formulations |
| 09/03/2009 | WO2009067520A3 Peptides specific for hepatocellular carcinoma cells and applications thereof |
| 09/03/2009 | WO2009065507A3 Pharmaceutical compositions containing bradykinin antagonists and hyaluronic acid, and uses thereof |
| 09/03/2009 | WO2009059748A3 Compositions for the topical protection of the ocular tissues from the damaging effects of ultraviolet radiations |
| 09/03/2009 | WO2009059717A3 Pharmaceutical compositions containing statins and omega-3 fatty acids derivatives and their solid formulations for oral use |
| 09/03/2009 | WO2009047633A3 Process for the manufacure of a pharmaceutical product comprising citric acid, magnesium oxide, potassium bicarbonate and sodium picosulfate, pharmaceutical composition comprising granules obtained by such process and intermediate |
| 09/03/2009 | WO2009042895A3 Reagents for inducing an immune response |
| 09/03/2009 | WO2009013562A3 Absorbable solid compositions for the topical treatment of oral mucosal disorders |
| 09/03/2009 | WO2008144185A3 Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods |
| 09/03/2009 | WO2008059502A3 Contact lens compositions |
| 09/03/2009 | WO2006041527A9 Penetrating carrier, anti-fungal composition using the same and method for treatment of dermatophytes |
| 09/03/2009 | US20090221953 Composition comprising protein-liposome complex for iontophoresis |
| 09/03/2009 | US20090221560 Pharmaceutical Formulation |
| 09/03/2009 | US20090221536 Transdermal delivery of beneficial substances effected by a hostile biophysical environment |
| 09/03/2009 | US20090221497 Immunodynamic complexes and methods for using and preparing such complexes |
| 09/03/2009 | US20090221489 Water-Soluable Films Comprising Low-Viscosity Alginates |
| 09/03/2009 | US20090221475 Treatment of lung disorders |
| 09/03/2009 | US20090220746 Storage Wrap Material |
| 09/03/2009 | US20090220621 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
| 09/03/2009 | US20090220615 Main Chain Acid-Degradable Polymers for the Delivery of Bioactive Materials |
| 09/03/2009 | US20090220614 Thermo-Responsive Block Co-Polymers, and Use Thereof |
| 09/03/2009 | US20090220613 Controlled release delivery device comprising an organosol coat |
| 09/03/2009 | US20090220612 Hollow-fibre-based biocompatible drug delivery device with one or more layers |
| 09/03/2009 | US20090220611 Microparticles With Modified Release of At Least One Active Principle and Oral Pharmaceutical Form Comprising Same |
| 09/03/2009 | US20090220610 Suspension Comprising Benzimidazole Carbamate and a Polysorbate |
| 09/03/2009 | US20090220609 Process to control particle size |
| 09/03/2009 | US20090220608 Pharmaceutical composition of microspheres for preventing diabetic foot amputation |
| 09/03/2009 | US20090220606 Treatment and prevention of abnormal cellular proliferation |
| 09/03/2009 | US20090220605 Bone matrix compositions having nanoscale textured surfaces |
| 09/03/2009 | US20090220604 Amino acids in micelle preparation |
| 09/03/2009 | US20090220603 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics |
| 09/03/2009 | US20090220602 Sublimable sustained release delivery system and method of making same |
| 09/03/2009 | US20090220601 Autologous Oral Grafts |
| 09/03/2009 | US20090220599 Antifungal formulation and manufacturing method thereof |
| 09/03/2009 | US20090220598 Stable Oral Pharmaceutical Composition Containing Thyroid Hormone Receptor Agonists |
| 09/03/2009 | US20090220597 Rapid release irbesartan-containing pharmaceutical composition |
| 09/03/2009 | US20090220596 Composition and Dosage Form Comprising a Solid or Semi-Solid Matrix |
| 09/03/2009 | US20090220595 Combination of erythropoietin glycoisoforms |
| 09/03/2009 | US20090220594 Tablet of Paracetamol Containing an Encapsulated Flavorant |
| 09/03/2009 | US20090220593 Extended release dosage forms of quetiapine |
| 09/03/2009 | US20090220592 Preparation for the treatment of tinnitus |
| 09/03/2009 | US20090220591 Pharmaceutical Compositions Comprising Non-Steroidal Antiinflammatory Drug, Antipyretic-Analgesic Drug and Proton Pump Inhibotor |
| 09/03/2009 | US20090220590 Triple drug combinations for psychiatric patients |
| 09/03/2009 | US20090220589 Treatment, diagnostic, and method for discovering antagonist using sparc specific mirnas |
| 09/03/2009 | US20090220588 Simultaneous Delivery of Receptors and/or Co-Receptors for Growth Factor Stability and Activity |
| 09/03/2009 | US20090220587 Liposomal drug delivery constructs targeted by lipid-conjugated peptide ligands |
| 09/03/2009 | US20090220586 Proteomimetic compounds as inhibitors of the interaction of nuclear receptor with coactivator peptides |
| 09/03/2009 | US20090220585 Biological Active Blood Serum Fraction S-1-10, Methods for Producing It and Uses Thereof |
| 09/03/2009 | US20090220584 Amphoteric Liposome Formulation |
| 09/03/2009 | US20090220583 Method and composition for treating inflammatory disorders |